Clinuvel Pharmaceuticals Limited Share Price
Stocks
CUV
AU000000CUV3
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.06 AUD | +1.11% |
|
+1.41% | -19.26% |
| Market Cap | 51Cr 35Cr 31Cr 29Cr 27Cr 50Cr 3.42TCr 344.09Cr 134.43Cr 1.68TCr 133.18Cr 130.31Cr 5.81TCr | P/E 2026 * |
14.2x | P/E 2027 * | 13.4x |
|---|---|---|---|---|---|
| Enterprise Value | 25Cr 18Cr 16Cr 15Cr 13Cr 25Cr 1.71TCr 172.73Cr 67Cr 843.13Cr 67Cr 65Cr 2.92TCr | EV / Sales 2026 * |
2.57x | EV / Sales 2027 * | 2.13x |
| Free-Float |
83.79% | Yield 2026 * |
0.61% | Yield 2027 * | 0.8% |
Last Transcript: Clinuvel Pharmaceuticals Limited
| 1 day | +1.11% | ||
| 1 week | +1.41% | ||
| Current month | -2.14% | ||
| 1 month | +0.10% | ||
| 3 months | +11.28% | ||
| 6 months | -17.41% | ||
| Current year | -19.26% |
| 1 week | 9.75 |  | 10.42 |
| 1 month | 9.72 | | 10.74 |
| Current year | 8.35 | | 13.48 |
| 1 year | 8.35 | | 14 |
| 3 years | 8.35 | | 21.45 |
| 5 years | 8.35 | | 44.67 |
| 10 years | 4.75 | | 45.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 63 | 01/11/2005 |
Peter Vaughan
DFI | Director of Finance/CFO | 42 | 30/06/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Guy van Dievoet
BRD | Director/Board Member | - | 06/09/2024 |
Karen Agersborg
BRD | Director/Board Member | - | 29/01/2018 |
Susan Smith
BRD | Director/Board Member | - | 23/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/10/24 | Buy | Director | 8,333 | 0.0166% | ||
| 27/11/23 | Fiscal year | Chief Executive Officer | 3,01,125 | 0.6094% | ||
| 27/11/23 | Expiration | Chief Executive Officer | 15,13,750 | 3.0636% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.11% | +1.41% | -15.39% | -45.39% | 35Cr | |
| +0.63% | -3.06% | +16.50% | -10.12% | 6.67TCr | |
| +1.23% | +2.80% | +38.09% | +200.66% | 5.33TCr | |
| +10.08% | +51.80% | +51.80% | +51.80% | 4.81TCr | |
| -1.32% | -7.38% | -57.37% | -56.96% | 3.83TCr | |
| +0.78% | -1.84% | +53.73% | -25.20% | 2.99TCr | |
| +0.84% | +0.36% | +67.62% | +84.46% | 2.35TCr | |
| -5.17% | -12.54% | +58.33% | -55.63% | 2.15TCr | |
| -1.21% | +1.12% | +0.90% | +164.17% | 2TCr | |
| -0.22% | -0.95% | +62.78% | +123.12% | 1.64TCr | |
| Average | +0.68% | -0.75% | +27.70% | +43.09% | 3.18TCr | |
| Weighted average by Cap. | +1.41% | -0.11% | +28.04% | +49.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.92Cr 6.93Cr 6.09Cr 5.66Cr 5.2Cr 9.77Cr 667.78Cr 67Cr 26Cr 328.3Cr 26Cr 25Cr 1.14TCr | 10Cr 7.33Cr 6.43Cr 5.98Cr 5.49Cr 10Cr 705.55Cr 71Cr 28Cr 346.87Cr 28Cr 27Cr 1.2TCr |
| Net income | 3.58Cr 2.5Cr 2.2Cr 2.04Cr 1.87Cr 3.52Cr 240.75Cr 24Cr 9.47Cr 118.36Cr 9.39Cr 9.18Cr 409.24Cr | 3.78Cr 2.64Cr 2.32Cr 2.16Cr 1.98Cr 3.72Cr 254.33Cr 26Cr 10Cr 125.04Cr 9.91Cr 9.7Cr 432.33Cr |
| Net Debt | -25Cr -18Cr -16Cr -14Cr -13Cr -25Cr -1.7TCr -171.36Cr -67Cr -836.47Cr -66Cr -65Cr -2.89TCr | -28Cr -20Cr -17Cr -16Cr -15Cr -28Cr -1.92TCr -193Cr -75Cr -942.07Cr -75Cr -73Cr -3.26TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | A$10.06 | +1.11% | 77,255 |
| 23/26/23 | A$9.950 | +0.71% | 74,171 |
| 22/26/22 | A$9.880 | -1.69% | 84,373 |
| 21/26/21 | A$10.05 | -1.86% | 1,52,029 |
| 20/26/20 | A$10.24 | +3.23% | 2,11,352 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CUV Stock
Select your edition
All financial news and data tailored to specific country editions
